Investor has been granted a patent for a mobile negative pressure wound therapy (NPWT) device. The device features a fluid connection to a wound site, a canister for liquid collection, a pump for negative pressure, and control circuitry that manages a start-up test sequence based on pressure readings. GlobalData’s report on Investor gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Investor, Distributed control systems was a key innovation area identified from patents. Investor's grant share as of June 2024 was 54%. Grant share is based on the ratio of number of grants to total number of patents.
Mobile negative pressure wound therapy device with control circuitry
The patent US12042596B2 describes a mobile negative pressure wound therapy (NPWT) device designed to facilitate the treatment of wounds by maintaining a negative pressure environment. The device includes several key components: an inlet for fluid connection with the wound site, a canister for liquid collection, a pump to establish negative pressure, and a pressure sensor to monitor the canister's pressure. The control circuitry is programmed to manage the device's operation, including a start-up test sequence that evaluates the pressure readings from the sensor. Depending on whether the initial pressure is above or below a predefined threshold, the device either activates the pump for a set duration or proceeds directly with the start-up sequence, ultimately determining if the device can transition to therapy mode based on predefined criteria.
Additionally, the patent outlines methods for testing the NPWT device's functionality, including evaluating pressure signals to confirm operational integrity. The device can also assess the performance of its pressure sensor and includes features to monitor battery performance through a speaker's operation. The NPWT system described in the patent further incorporates a chamber for negative pressure establishment, connected to the NPWT device via tubing. This comprehensive design aims to enhance the reliability and effectiveness of negative pressure wound therapy, ensuring that the device operates correctly before commencing treatment.
To know more about GlobalData’s detailed insights on Investor, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
